NICE GUIDELINES

NICE provides NATIONAL GUIDANCE and RECOMMENDATIONS for healthcare in the UK.

NICE guidelines are evidence-based recommendations for health and care in England.

They set out the care and services suitable for most people with a specific condition or need, and people in particular circumstances or settings.

Our guidelines help health and social care professionals to:

  • prevent ill health
  • promote and protect good health
  • improve the quality of care and services
  • adapt and provide health and social care services.

All our guidance applies to Wales too. You can find out more on the Welsh Government website.

Find NICE guidelines

View important dates in the development process and links to all guidelines in development (Excel).

Guideline types

  • clinical
  • social care
  • public health
  • medicines practice
  • cancer services
  • antimicrobial prescribing.
How we develop our guidelines

We work with health and care professionals, people who use services and carers to draft our recommendations. Find out how we choose our topics, draft and publish our guidelines.

Making decisions using our guidelines

Our guidelines can help you make decisions around prescribing medicines, what treatments to recommend and the promotion of safeguarding.

How to get involved

You can help draft our guidelines by registering as a stakeholder or joining a guideline committee.

Shared decision making

Our guidelines support shared decision making between healthcare professionals and those receiving care and treatment.

Maintaining and updating our guideline portfolio

We’re changing how we manage and maintain our guidelines by prioritising which topics we monitor and update.

Interim clinical guideline surveillance process and methods guide 2013

Interim clinical guideline surveillance process and methods guide 2013

Interim process and methods guide for the clinical guideline updates using standing committees pilot programmed 2013

Interim process and methods guide for the clinical guideline updates using standing committees pilot programmed 2013

COVID-19 rapid guideline: managing COVID-19

COVID-19 rapid guideline: managing COVID-19

Early and locally advanced breast cancer: diagnosis and management

Early and locally advanced breast cancer: diagnosis and management

Cardiovascular disease: risk assessment and reduction, including lipid modification

Cardiovascular disease: risk assessment and reduction, including lipid modification

Caesarean birth

Caesarean birth

Hypertension in pregnancy: diagnosis and management

Hypertension in pregnancy: diagnosis and management

Lung cancer: diagnosis and management

Lung cancer: diagnosis and management

Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management

Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management

Delirium: prevention, diagnosis and management in hospital and long-term care

Delirium: prevention, diagnosis and management in hospital and long-term care

Tobacco: preventing uptake, promoting quitting and treating dependence

Tobacco: preventing uptake, promoting quitting and treating dependence

Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education

Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education

Hip fracture: management

Hip fracture: management

Guideline

2024

CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack (New)

In development [GID-DG10054]Expected publication date: 31 July 2024 

Asthma: diagnosis, monitoring and chronic asthma management (New)

In development [GID-NG10186] Expected publication date: 27 November 2024 

Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer (New)

Published: 13 December 2023

Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus (New)

Interventional procedures guidance [IPG789] Published: 20 June 2024 

Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (New)

Technology appraisal guidance Reference number:TA984 Published: 19 June 2024

Ovarian cancer: identifying and managing familial and genetic risk (New)

NICE guideline [NG241] Published: 21 March 2024

2023

Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment

Interventional procedures guidance [IPG772] Published: 21 September 2023

Endometriosis: diagnosis and management

NICE guideline [NG73] Published: 06 September 2017  Last updated: 16 April 2024

Proov Confirm for ovulation confirmation

Medtech innovation briefing [MIB322] Published: 06 June 2023

Intrapartum care

NICE guideline [NG235] Published: 29 September 2023